Position in ALNY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$258,078
-$73,164 QoQ
Shares Held
780
-6.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MGO ONE SEVEN LLC holds $4,461,228 across 10 Biotechnology names. ALNY ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,265 | $1,457,953 | |
| 2 | RLMD |
Relmada Therapeutics, Inc.
|
100,000 | $696,000 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
649 | $501,443 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
7,348 | $474,901 | |
| 5 | ARGX |
Argenx SE
|
590 | $430,847 | |
| 6 | MDWD |
MediWound Ltd.
|
22,163 | $357,045 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
780 | $258,078 | |
| 8 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
26,817 | $207,027 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $258,078 | 780 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $331,242 | 833 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $319,200 | 700 | Shares | Sole | 2025-10-24 | |
| No filing history on record for this holder in this stock. | ||||||